Company Overview of Arbutus Biopharma Corporation
Keith S. Manchester M.D.
Independent Director and Chairman of Corporate Governance & Nominating Committee, Arbutus Biopharma Corporation
|Age||Total Calculated Compensation||This person is connected to 2 Board Members in 2 different organizations across 3 different industries.|
See Board Relationships
100-8900 Glenlyon ParkwayPhone: 604-419-3200
Burnaby, British Columbia V5J 5J8
Board Members Memberships
Independent Director and Chairman of Corporate Governance & Nominating Committee
Harvard Medical School
Annual CompensationThere is no Annual Compensation data available.
Stocks OptionsThere is no Stock Options data available.
Total CompensationThere is no Total Compensation data available.
|Ali Mortazavi||Chief Executive and Director|
Silence Therapeutics plc
|Gregory West CA||Interim Chief Executive Officer, Chief Financial Officer and Company Secretary|
Benitec Biopharma Limited
|Mark W. Schwartz Ph.D.||Chief Executive Officer, President, Director and Member of Ad Hoc (Strategy, Pricing, Etc) Committee|
Galena Biopharma, Inc.
|Paul C. Grint M.D.||Chief Executive Officer, President and Director|
Regulus Therapeutics Inc.
|Douglas M. Fambrough III, Ph.D.||Co-Founder, Chief Executive Officer, President and Director|
Dicerna Pharmaceuticals, Inc.
|$430.0K||Compensation as of Fiscal Year 2014.|